Levin Capital Strategies, L.P. Renalytix PLC Transaction History
Levin Capital Strategies, L.P.
- $952 Million
- Q2 2024
A detailed history of Levin Capital Strategies, L.P. transactions in Renalytix PLC stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 555,000 shares of RNLX stock, worth $160,950. This represents 0.01% of its overall portfolio holdings.
Number of Shares
555,000Holding current value
$160,950% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RNLX
# of Institutions
29Shares Held
3.72MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD815KShares$236,4730.0% of portfolio
-
Stifel Financial Corp St. Louis, MO561KShares$162,6900.0% of portfolio
-
Tejara Capital LTD London, X0500KShares$145,1140.04% of portfolio
-
Ci Private Wealth, LLC Miami, FL336KShares$97,2990.0% of portfolio
-
Gofen & Glossberg LLC188KShares$54,5840.01% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $10.9M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...